Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Scientific Reports|March 25, 2021
CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineeringKatherine S Wetzel, Carlos A Guerrero-Bustamante, Rebekah M Dedrick, et al.Microbiology Spectrum|November 3, 2025
Amplification, purification, and lyophilization of mycobacteriophages for therapeutic useMaggie D Viland, Lawrence Abad, Deborah Jacobs-Sera, et al.Open Forum Infectious Diseases|July 7, 2022
Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung DiseaseRebekah M Dedrick, Krista G Freeman, Jan A Nguyen, et al.Nature Medicine|July 9, 2021
Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infectionRebekah M Dedrick, Krista G Freeman, Jan A Nguyen, et al.Cell Host & Microbe|June 17, 2023
Virion glycosylation influences mycobacteriophage immune recognitionKrista G Freeman, Anna C Robotham, Olivia B Parks, et al.Virology Journal|January 20, 2025
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of deliveryThomas Smytheman, Tiffany Pecor, Dana E Miller, et al.Cell|April 16, 2025
Structure and infection dynamics of mycobacteriophage Bxb1Krista G Freeman, Sudipta Mondal, Lourriel S Macale, et al.Cell Reports|July 25, 2025
Cryo-EM and cryo-ET reveal the molecular architecture and host interactions of mycobacteriophage DougeJitendra Maharana, Chun-Hsiung Wang, Li-An Tsai, et al.Cell|May 14, 2022
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.Pageof 3